Early bactericidal activity studies monitor daily sputum bacterial counts in individuals with
tuberculosis (TB) for 14 days during experimental drug treatment. The rate of change in sputum …

Background Fluoroquinolones and second-line injectable drugs are the backbone of
treatment regimens for multidrug-resistant tuberculosis, and resistance to these drugs defines …

A cluster of 3 facial Mycobacterium chelonae infections occurred after cosmetic dermal filler
injections at a plastic surgery clinic. Pulsed-field gel electrophoresis showed that M …

Sensitive, accessible, and biosafe sampling methods for COVID-19 reverse-transcriptase
polymerase chain reaction (RT-PCR) assays are needed for frequent and widespread testing. …

Background and Objective Quantifying exposure to drugs for personalized dose adjustment
is of critical importance in patients with tuberculosis who may be at risk of treatment failure or …

Variable pharmacokinetics of rifampin in tuberculosis (TB) treatment can lead to poor
outcomes. Urine spectrophotometry is simpler and more accessible than recommended serum-…

The current active–latent paradigm of tuberculosis largely neglects the documented spectrum
of disease. Inconsistency with regard to definitions, terminology, and diagnostic criteria for …

Background COVID-19 is a multi-system infection with emerging evidence-based antiviral
and anti-inflammatory therapies to improve disease prognosis. However, a subset of patients …

Saliva has been a COVID-19 diagnostic specimen of interest due to its simple collection,
scalability, and yield. Yet COVID-19 testing and estimates of the infectious period remain …

Successful tuberculosis (TB) therapy requires achieving sufficient exposure to multiple drugs.
Limited stability of several first-line anti-TB drugs might compromise reliable therapeutic …